Literature DB >> 33473103

p53 is required for nuclear but not mitochondrial DNA damage-induced degeneration.

Matthew J Geden1,2, Selena E Romero1,2, Mohanish Deshmukh3,4.   

Abstract

While the consequences of nuclear DNA damage have been well studied, the exact consequences of acute and selective mitochondrial DNA (mtDNA) damage are less understood. DNA damaging chemotherapeutic drugs are known to activate p53-dependent apoptosis in response to sustained nuclear DNA damage. While it is recognized that whole-cell exposure to these drugs also damages mtDNA, the specific contribution of mtDNA damage to cellular degeneration is less clear. To examine this, we induced selective mtDNA damage in neuronal axons using microfluidic chambers that allow for the spatial and fluidic isolation of neuronal cell bodies (containing nucleus and mitochondria) from the axons (containing mitochondria). Exposure of the DNA damaging drug cisplatin selectively to only the axons induced mtDNA damage in axonal mitochondria, without nuclear damage. We found that this resulted in the selective degeneration of only the targeted axons that were exposed to DNA damage, where ROS was induced but mitochondria were not permeabilized. mtDNA damage-induced axon degeneration was not mediated by any of the three known axon degeneration pathways: apoptosis, axon pruning, and Wallerian degeneration, as Bax-deficiency, or Casp3-deficiency, or Sarm1-deficiency failed to protect the degenerating axons. Strikingly, p53, which is essential for degeneration after nuclear DNA damage, was also not required for degeneration induced with mtDNA damage. This was most evident when the p53-deficient neurons were globally exposed to cisplatin. While the cell bodies of p53-deficient neurons were protected from degeneration in this context, the axons farthest from the cell bodies still underwent degeneration. These results highlight how whole cell exposure to DNA damage activates two pathways of degeneration; a faster, p53-dependent apoptotic degeneration that is triggered in the cell bodies with nuclear DNA damage, and a slower, p53-independent degeneration that is induced with mtDNA damage.

Entities:  

Year:  2021        PMID: 33473103      PMCID: PMC7817838          DOI: 10.1038/s41419-020-03373-1

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  66 in total

Review 1.  Mitochondrial fission, fusion, and stress.

Authors:  Richard J Youle; Alexander M van der Bliek
Journal:  Science       Date:  2012-08-31       Impact factor: 47.728

Review 2.  The maintenance of mitochondrial DNA integrity--critical analysis and update.

Authors:  Mikhail Alexeyev; Inna Shokolenko; Glenn Wilson; Susan LeDoux
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

Review 3.  A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.

Authors:  Douglas C Wallace
Journal:  Annu Rev Genet       Date:  2005       Impact factor: 16.830

4.  Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma.

Authors:  Geetha Achanta; Ryohei Sasaki; Li Feng; Jennifer S Carew; Weiqin Lu; Helene Pelicano; Michael J Keating; Peng Huang
Journal:  EMBO J       Date:  2005-09-15       Impact factor: 11.598

5.  Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons.

Authors:  Jewel L Podratz; Andrew M Knight; Lauren E Ta; Nathan P Staff; Jennifer M Gass; Konstantin Genelin; Alexander Schlattau; Liselle Lathroum; Anthony J Windebank
Journal:  Neurobiol Dis       Date:  2010-12-08       Impact factor: 5.996

6.  Double-strand breaks of mouse muscle mtDNA promote large deletions similar to multiple mtDNA deletions in humans.

Authors:  Sarika Srivastava; Carlos T Moraes
Journal:  Hum Mol Genet       Date:  2005-02-09       Impact factor: 6.150

Review 7.  The QPCR assay for analysis of mitochondrial DNA damage, repair, and relative copy number.

Authors:  Senyene E Hunter; Dawoon Jung; Richard T Di Giulio; Joel N Meyer
Journal:  Methods       Date:  2010-02-01       Impact factor: 3.608

Review 8.  Axon degeneration: context defines distinct pathways.

Authors:  Matthew J Geden; Mohanish Deshmukh
Journal:  Curr Opin Neurobiol       Date:  2016-05-16       Impact factor: 6.627

9.  A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside.

Authors:  C N Anderson; A M Tolkovsky
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

10.  Distinct pathways mediate axon degeneration during apoptosis and axon-specific pruning.

Authors:  Corey L Cusack; Vijay Swahari; W Hampton Henley; J Michael Ramsey; Mohanish Deshmukh
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  2 in total

Review 1.  Mitochondrial DNA damage as driver of cellular outcomes.

Authors:  Cristina A Nadalutti; Sylvette Ayala-Peña; Janine H Santos
Journal:  Am J Physiol Cell Physiol       Date:  2021-12-22       Impact factor: 4.249

Review 2.  Genes and Longevity of Lifespan.

Authors:  May Nasser Bin-Jumah; Muhammad Shahid Nadeem; Sadaf Jamal Gilani; Fahad A Al-Abbasi; Inam Ullah; Sami I Alzarea; Mohammed M Ghoneim; Sultan Alshehri; Aziz Uddin; Bibi Nazia Murtaza; Imran Kazmi
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.